## **Core Concept**
Lung cancer is broadly classified into two main types based on histopathology: Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). The prognosis and treatment approach vary significantly between these types. SCLC is known for its aggressive behavior and poor prognosis.

## **Why the Correct Answer is Right**
Small Cell Lung Cancer (SCLC) accounts for about 15-20% of lung cancers. It grows and spreads much faster than NSCLC. SCLC has a strong association with cigarette smoking and tends to be at an advanced stage at the time of diagnosis. Due to its rapid growth and early metastasis, SCLC has a poorer prognosis compared to NSCLC.

## **Why Each Wrong Option is Incorrect**
- **Option A:** NSCLC (if this is option A) includes several subtypes like adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. NSCLC accounts for about 80-85% of lung cancers and generally has a better prognosis than SCLC, especially if caught early.
- **Option B and C:** Without specific details on options B and C, it's assumed they refer to other types or aspects of lung cancer not directly related to the question's focus on poor prognosis.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that SCLC is highly sensitive to chemotherapy and radiotherapy, which can be a treatment advantage. However, its aggressive nature and tendency to recur make its overall prognosis poor. A classic clinical correlation is that SCLC can cause **Ectopic Hormone Syndromes**, such as the syndrome of inappropriate antidiuretic hormone secretion (SIADH).

## **Correct Answer:** D. SCLC (Small Cell Lung Cancer).